Endpoints News 生物医药· Anna Brown·· 8 天前AI 评分27
Merck KGaA 因 Lonza 协议减值 3.66 亿欧元
Merck KGaA's writedown over Lonza deal; PharmaLogic buys Lantheus' CDMO business
AI 导读
Merck KGaA 因向 Lonza 销售合同计提 3.66 亿欧元减值损失。PharmaLogic 购买了 Lantheus 的 CDMO 业务。
正文
Merck KGaA’s impairment hit from CDMO sale: The German conglomerate reported a €366 million ($405.8 million) impairment loss on its business sale to Lonza, according …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news